Immunotherapy for tumor metastasis by artificial antigen-presenting cells via targeted microenvironment regulation and T-cell activation
Y Lu, L Li, J Du, J Chen, X Xu, X Yang… - … Applied Materials & …, 2021 - ACS Publications
… 2 , guaranteeing the survival and function of antitumor immune cells. When modified with
anti-CD3/… tumor homing ability and antitumor immune response by activating DCs and CD8 + T-…
anti-CD3/… tumor homing ability and antitumor immune response by activating DCs and CD8 + T-…
[HTML][HTML] HLA-class II artificial antigen presenting cells in CD4+ T cell-based immunotherapy
A Couture, A Garnier, F Docagne, O Boyer… - Frontiers in …, 2019 - frontiersin.org
… CD4 + T cells have direct roles in anti-tumor and anti-viral … , can elicit robust specific CD4 +
T cell responses in vitro (96, 97). … of Th cells is more adapted to mediate a protective response …
T cell responses in vitro (96, 97). … of Th cells is more adapted to mediate a protective response …
Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by nanoscale artificial antigen-presenting cells
J Ichikawa, T Yoshida, A Isser, AS Laino… - Clinical Cancer …, 2020 - AACR
… , these cellular attributes characterize T cells with antitumor … − [(target cell number in the
presence of effector cells)/(target … T-cell persistence in vivo and durability of ACT responses (51…
presence of effector cells)/(target … T-cell persistence in vivo and durability of ACT responses (51…
Orchestrated codelivery of peptide antigen and adjuvant to antigen-presenting cells by using an engineered chimeric peptide enhances antitumor T-cell immunity
…, S Zhang, Q Yuan, C Huang, T Zhang, T Li… - Cancer Immunology …, 2024 - AACR
… limitations, including the use of synthetic particles (3, 18); … , complete protection against
rechallenge with MC38 cells on day … eTAT elicited a robust Ag-specific CD8+ T-cell response not …
rechallenge with MC38 cells on day … eTAT elicited a robust Ag-specific CD8+ T-cell response not …
Direct Presentation of Tumor‐Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell‐Mimicking Nanovaccines
… antigen-presenting cells (APCs), priming of CD4 + or CD8 + … and cross-presented to
elicit cytotoxic T lymphocytes (CTLs). [ … (HPLC) confirmed the successful synthesis of 2′3′-cGAMP …
elicit cytotoxic T lymphocytes (CTLs). [ … (HPLC) confirmed the successful synthesis of 2′3′-cGAMP …
Assessing the efficacy of a tumor nanovaccine and artificial antigen presenting cell-based system as a combination therapy in a mouse model of melanoma
S Song, H Xu, Y Yang, Q Wan, B He… - Journal of …, 2022 - ingentaconnect.com
… vaccines alone can elicit a broad immune response, their … in studies that can promote CD4
+ T cell expansion and increase … + T cells in the antitumor efficacy of the combination therapy, …
+ T cell expansion and increase … + T cells in the antitumor efficacy of the combination therapy, …
Nanoparticles for generating antigen-specific T cells for immunotherapy
… There is also variation depending on the T cell activation … less efficient than cell based
artificial antigen presenting cells (… targeted for eliciting an antigen-specific T cell response. These …
artificial antigen presenting cells (… targeted for eliciting an antigen-specific T cell response. These …
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses
CG Kim, YC Kye, CH Yun - Pharmaceutics, 2019 - mdpi.com
… , which are essential for antiviral and anticancer therapies. … an aim to induce protective immune
responses by targeting DCs. For … Considering both safety and efficiency, various synthetic …
responses by targeting DCs. For … Considering both safety and efficiency, various synthetic …
Lipid–Polymer Hybrid Nanoparticles Utilize B Cells and Dendritic Cells to Elicit Distinct Antigen-Specific CD4+ and CD8+ T Cell Responses
… to antigen-presenting cells (APCs), the primary mediators of … design of novel APC-targeted
therapeutic interventions for ex … coculture studies using PMEL T cells, synthesis and 1 H NMR …
therapeutic interventions for ex … coculture studies using PMEL T cells, synthesis and 1 H NMR …
[HTML][HTML] An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
K Ye, F Li, R Wang, T Cen, S Liu, Z Zhao, R Li, L Xu… - Molecular Therapy, 2022 - cell.com
… tumor cells into artificial antigen-presenting cells (aAPCs) by … local signals for optimum T
cell activation. The infected tumor … models and elicited an antitumor immunological memory. In …
cell activation. The infected tumor … models and elicited an antitumor immunological memory. In …